TMUS Financial Statements & Analysis
Complete financial statements for TMUS including income statement, balance sheet, and cash flow statement. Analyze TMUS's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
55
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
3.6% ↑
Net Income
36.3% ↑
Gross Margin
3.2% ↑
Operating Margin
21.8% ↑
Balance Sheet
Current Ratio
0.4% ↑
Debt to Equity
5.6% ↓
Asset Turnover
3.4% ↑
Cash Flow
Operating Cash Flow
20.1% ↑
Net Cash Flow
-35.9% ↓
Free Cash Flow
28.8% ↑
Cash Flow to Debt
19.2% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 78.56B | 81.40B | 3.6% | |
| Gross Profit | 48.37B | 51.75B | 7.0% | |
| Operating Income | 14.27B | 18.01B | 26.2% | |
| Net Income | 8.32B | 11.34B | 36.3% | |
| EPS | 7.02 | 9.7 | 38.2% | |
| EBITDA | 27.15B | 31.04B | 14.3% | |
| Gross Margin | 61.57% | 63.57% | 3.2% | |
| Operating Margin | 18.16% | 22.13% | 21.8% | |
| Net Income Margin | 10.59% | 13.93% | 31.6% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 81.40B | 78.56B | 79.57B | 80.12B | 68.40B |
| Gross Profit | 51.75B | 48.37B | 43.37B | 43.51B | 40.13B |
| Operating Income | 18.01B | 14.27B | 6.54B | 6.89B | 6.64B |
| Net Income | 11.34B | 8.32B | 2.59B | 3.02B | 3.06B |
| EPS | 9.7 | 7.02 | 2.07 | 2.42 | 2.68 |
| EBITDA | 31.04B | 27.15B | 20.16B | 23.08B | 20.38B |
| Gross Margin | 63.57% | 61.57% | 54.50% | 54.31% | 58.67% |
| Operating Margin | 22.13% | 18.16% | 8.22% | 8.60% | 9.70% |
| Net Income Margin | 13.93% | 10.59% | 3.25% | 3.77% | 4.48% |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 |